KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Non-Current Assets (2016 - 2025)

Edwards Lifesciences has reported Non-Current Assets over the past 17 years, most recently at $7.0 billion for Q4 2025.

  • Quarterly results put Non-Current Assets at $7.0 billion for Q4 2025, up 2.78% from a year ago — trailing twelve months through Dec 2025 was $27.6 billion (up 14.2% YoY), and the annual figure for FY2025 was $7.0 billion, up 2.78%.
  • Non-Current Assets for Q4 2025 was $7.0 billion at Edwards Lifesciences, up from $6.9 billion in the prior quarter.
  • Over the last five years, Non-Current Assets for EW hit a ceiling of $7.0 billion in Q4 2025 and a floor of $4.1 billion in Q1 2021.
  • Median Non-Current Assets over the past 5 years was $5.3 billion (2023), compared with a mean of $5.6 billion.
  • Biggest five-year swings in Non-Current Assets: increased 28.36% in 2021 and later fell 2.35% in 2022.
  • Edwards Lifesciences' Non-Current Assets stood at $5.3 billion in 2021, then fell by 2.35% to $5.2 billion in 2022, then rose by 2.52% to $5.3 billion in 2023, then rose by 27.07% to $6.8 billion in 2024, then grew by 2.78% to $7.0 billion in 2025.
  • The last three reported values for Non-Current Assets were $7.0 billion (Q4 2025), $6.9 billion (Q3 2025), and $6.9 billion (Q2 2025) per Business Quant data.